Primary Prevention of Hypertension in Obese Adolescents
Completed · Phase 2 · Has a placebo group
Conditions studied: Obesity, Pre-Hypertension, Hyperuricemia
In brief
The purpose of this study is to examine the consequences of lowering serum uric acid in pre-hypertensive, obese adolescents pathways involved with how uric acid mediated hypertension and renal disease. The specific aims are: 1. Test the hypothesis that lowering uric acid will improve endothelial function. 2. Test the hypothesis that lowering uric acid will reduce plasma renin activity and serum angiotensin II levels. 3. Test the hypothesis that lowering uric acid will reduce markers of inflammation
Key facts
- Study ID
- NCT00288158
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 60
- Starts
- 2008-09-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2017-09-14
Who can join
Age: 11 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Children between the ages of 11 and 18
- body mass index greater than the 95th percentile for age
- Blood pressure between 75th and 95th percentile for age, gender and height percentile
You may not qualify if…
- hypertension at the time of screening
- allergy to one of the study medications
- liver function abnormality (AST or ALT greater than twice the upper limit of
- normal for the laboratory)
- history of renal stones
- renal insufficiency (Schwartz formula calculated GFR less than 70ml per min per 1.73m2 BSA)
- positive urine pregnancy test
- diabetes
- organ transplant recipient
- currently treated with an angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), diuretic, other medications known to alter serum uric acid level
- lack of ability to comply with the study protocol
Where it is running
- Texas Children's Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.